Metabolomics Market Size Worth USD 9.92 Billion in 2032 | Emergen Research

The global metabolomics market size was USD 2.58 Billion in 2022 and is expected to register a revenue CAGR of 14.6% during the forecast period. The global metabolomics market is experiencing significant growth, driven by various factors including the expansion of the healthcare industry, technological advancements, and increasing prevalence of chronic diseases. A recent market research report sheds light on the key drivers and insights shaping the metabolomics landscape.

Key Market Drivers:

1. Analytical Techniques: Metabolomics utilizes various analytical techniques such as spectroscopy, chromatography, and multivariate analysis, contributing to accurate determination of metabolites.
2. Prevalence of Chronic Diseases: Rising cases of chronic diseases globally, such as cardiovascular disorders and cancer, are fueling demand for advanced treatments and drug discovery, thereby boosting the metabolomics market.
3. Integration of AI, IoT, and ML: Technological advancements, including Artificial Intelligence (AI), Internet of Things (IoT), and Machine Learning (ML), are enhancing the efficiency and reliability of treatments, promising faster and more accurate procedures.
4. Revolutionary Breakthroughs in Technology: Innovative products launched by companies utilizing high-end technologies are driving market growth, with strategic measures like partnerships and new product launches further bolstering the landscape.

Get PDF Sample Report + All Related Table and Graphs @ https://www.emergenresearch.com/request-sample/2789

Market Restraints:
Despite the promising growth trajectory, challenges such as high costs associated with metabolomics instruments and data interpretation complexity restrain the market's revenue growth. Limited accessibility of advanced technologies in certain regions poses additional barriers to adoption.

Market Segmentation Insights:

1. Products & Services: The market is segmented into metabolomics instruments and metabolomics bioinformatics tools and services. While bioinformatics tools and services dominate the market, the instruments segment is expected to register the fastest growth during the forecast period.
2. Indications: Segments such as cancer and cardiovascular disorders hold significant market shares, driven by the increasing adoption of metabolomics in oncology and the rising prevalence of cardiovascular diseases globally.
3. End-Use: Academic and research institutes currently lead the market, with pharmaceutical and biotechnology companies anticipated to witness significant growth, driven by enhanced accessibility to treatment options.

Future Outlook:

With the healthcare industry's continued expansion, technological advancements, and increasing demand for personalized medicines, the metabolomics market is poised for robust growth in the coming years. Companies are expected to focus on innovation and strategic collaborations to capitalize on emerging opportunities.

Request a Discount on the Report @ https://www.emergenresearch.com/request-discount/2789

Metabolomics Top Companies and Competitive Landscape

The global metabolomics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Metabolomics solutions.

Some major players included in the global metabolomics market report are:

• Afekta Technologies Ltd.
• DNA Xperts Private Limited
• Metabolomic Technologies Inc.
• Agilent Technologies, Inc.
• MS-OMICS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• BASF SE
• Metabolon, Inc.

Metabolomics Latest Industry News

• In July 2021, Thermo Fisher Scientific Inc. and the University of California, Davis (UC Davis) launched the Center of Excellence in Clinical Metabolomics, a research collaboration to provide innovations, the best practices, and standard operating procedures to the metabolomics community.
• In December 2021, Dickinson and Company (BD) announced that "embecta" will be the name of the publicly traded company that will hold BD's Diabetes Care business.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2789

Metabolomics Market Segment Analysis

For the purpose of this report, Emergen Research has segmented global metabolomics market on the basis of products & services, application, indication, end-use, and region:

• Products & Services Outlook (Revenue, USD Billion; 2019-2032)
o Metabolomics instruments
o Metabolomics bioinformatics tools and services
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Drug discovery
o Biomarker discovery
o Nutrigenomics
o Functional genomics
o Personalized medicine
o Others
• Indication Outlook (Revenue, USD Billion; 2019-2032)
o Cancer
o Cardiovascular disorders
o Neurological disorders
o Others
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Academic and research institutes
o Contract research organizations
o Pharmaceutical and biotechnology companies
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of MEA

To Visit Full Report & Table of Contents @ https://www.emergenresearch.com/industry-report/metabolomics-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.